Skip to main content

Table 4 Pooled and pairwise comparisons of DFS among four chemotherapy regimens in patients with different TopIIα expression levels

From: Topoisomerase II alpha expression and the benefit of adjuvant chemotherapy for postoperative patients with non-small cell lung cancer

TopIIα expression Chemotherapy regimens Vinorelbine (P) Gemcitabine (P) Docetaxel (P) Paclitaxel (P) P for each stratum
Low expression stratum Vinorelbine   0.128 0.047* 0.322 0.267
  Gemcitabine 0.128   0.676 0.786  
  Docetaxel 0.047* 0.676   0.429  
  Paclitaxel 0.322 0.786 0.429   
High expression stratum Vinorelbine   0.209 0.410 0.437 0.594
  Gemcitabine 0.209   0.895 0.902  
  Docetaxel 0.410 0.895   0.987  
  Paclitaxel 0.437 0.902 0.987   
  1. * P < 0.05 was considered statistically significant